Tag: clinicaltrials

The Congolese National Medicines Regulatory Authority (DPM) with WHO to guarantee the development and circulation of safe and effective drugs, by implementing the Global Benchmarking Tool (GBT)

As part of the strengthening of health systems and in particular the regulation of drugs and health products within the Africlinique project, the headquarters of the World Health Organization (WHO), the WHO Regional Office for Africa (AFRO), and the WHO Country Office (PO) in the Republic of Congo provided technical assistance to support the Directorate of Pharmacy and Medicine (DPM) of Congo from February 15 to 19 2021 in Brazzaville (Republic of Congo).

The Global Benchmarking Tool (GBT) integrates the Maturity Level (ML) of the various drug regulatory functions in a computerized platform that facilitates its use and the ranking of maturity indicators. This self-assessment has enabled several countries in the sub-region to identify their ML as well as to put in place institutional development plans (IDPs) in order to access a ML which guarantees safety,  quality and effectiveness of drugs in development and in circulation.

Click here to for news release in English.

SEARCH project kick-off meeting

After months of intense preparation, the SEARCH (SouthErn Africa Regulatory for Clinical researcH) will have its project kick-off meeting. The Partners from all countries of SEARCH Consortium (Mozambique, Botswana, Eswatini, Lesotho and UK), together with the invited relevant stakeholders, will meet on February 18, 2021. Click here for more information: https://bit.ly/3jEUzFg
This EDCTP-funded project is aimed at increasing the regulatory capacities for review of clinical trials in Southern Africa by establishing European-African collaborations that facilitates implementation of efficient processes, harmonized procedures, standardized guidelines and effective training programs.

Exemplary coordination of African researchers and scientists

Exemplary coordination of African researchers and scientists involved in the response to the pandemic to study treatments that prevent serious complications of COVID-19 https://bit.ly/37SvaCz